4
Changes in Ownership
Mineralys Therapeutics, Inc. Filed Acc 0001933414-26-000095
Chief Commercial Officer sold 104,124 shares at $25.90 ($2,696,322)
- Chief Commercial Officer acquired 104,124 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Warren Eric Chief Commercial Officer | 2026-06-26 | Option exercise 10b5-1 | +104,124 | $13.24 | $1,378,602 | 142,524 | D |
| Warren Eric Chief Commercial Officer | 2026-06-26 | Sale 10b5-1 | −104,124 | $25.90 | $2,696,322 | 38,400 | D |
| Derivatives | |||||||
| Warren Eric Chief Commercial Officer | 2026-06-26 | Option exercise · Stock Option 10b5-1 | −104,124 | 252,876 | D | ||
| Open-market sales · 104,124 sh · avg $25.90 · $2,696,322 | |||||||
Loading xslF345X06/wk-form4_1782859276.xml…